Quarterly Loss

 
News Articles for Quarterly Loss top ^
2013/3/11
Gulf Island Fabrication, Inc. (NASDAQ: GIFI) today reported a net loss of $8.1 million ($.56 diluted loss per share) on revenue of $129.2 million for its fourth quarter ended December 31, 2012, compared to net income of $1.8 million ($.12 diluted EPS) on revenue of $88.4 million for the fourth quarter ended December 31, 2011.
Sign-up for Gulf Island Fabrication, Inc. Reports Fourth Quarter Loss investment picks
2013/4/30
-- Leap Wireless first-quarter loss widens; customer losses continue --Total subscribers drop 16% from year ago --Expects iPhone shortfall to resolve over time (Updates throughout with details and company comment beginning in the second paragraph.) By Thomas Gryta and Drew FitzGerald Leap Wireless International Inc.'s (LEAP) first-quarter loss widened as the discount mobile-phone service's customer base continued to erode.
Sign-up for UPDATE: Leap Wireless 1st-Quarter Loss Widens as Customer Losses Continue investment picks
2013/4/18
Advanced Micro Devices Inc.'s (AMD) first-quarter loss narrowed as the chip maker reported fewer charges from restructuring, masking a drop in revenue.
Sign-up for Advanced Micro Devices 1st-Quarter Loss Narrows Following Restructuring investment picks
2013/4/23
--CEO details focus on business outside mobility --Company to remodel some NYC stores --Plan comes after fifth straight quarterly loss (Adds fresh stock quote, details of new marketing plan starting in first paragraph.) By Drew FitzGerald RadioShack Corp.
Sign-up for 2nd UPDATE: RadioShack Posts Wider 1st-Quarter Loss investment picks
2013/4/23
--Company posts fifth-straight quarterly loss --Same-store sales slide 5.7% --CEO plans rebranding (Adds analyst commentary, additional details on earnings and executive changes.) By Drew FitzGerald RadioShack Corp.
Sign-up for UPDATE: RadioShack Posts Wider 1st-Quarter Loss investment picks
2013/4/30
Mindspeed Technologies Inc. (MSPD) said that it is evaluating strategic alternatives, retaining Morgan Stanley (MS) as a financial adviser.
Sign-up for Mindspeed Considers Strategic Options; 2nd-Quarter Loss Widens investment picks
2013/5/7
WebMD Health Corp.'s (WBMD) first-quarter loss narrowed as the health-information provider posted revenue growth and lower expenses and also said its chief executive is stepping down.
Sign-up for WebMD First-Quarter Loss Narrows; Chief Executive to Step Down investment picks
2013/5/8
MarkWest Energy Partners LP (MWE) swung to a first-quarter loss as the natural-gas processor was dragged down by a loss on redemption of debt and higher operating costs, though revenue was up.
Sign-up for MarkWest Energy Swings to 1st-Quarter Loss on Debt-Redemption Losses investment picks
2013/4/18
SAN FRANCISCO (MarketWatch) -- Advanced Micro Devices Inc. reported a narrower quarterly loss Thursday afternoon as revenues declined in the first quarter.
Sign-up for PULSE: AMD first-quarter loss narrows by 75% investment picks
2013/2/6
SAN FRANCISCO (MarketWatch) - Yelp Inc. posted a net loss with a strong jump in fourth-quarter revenue on Wednesday afternoon.
Sign-up for PULSE: Yelp reports quarterly loss, revenue jumps investment picks
2013/4/25
United Continental Holdings Inc.'s (UAL) first-quarter loss narrowed amid fewer merger-related charges and other items as the carrier also reported revenue growth.
Sign-up for United Continental Cuts 1st-Quarter Loss; Charges Down, Revenue Up investment picks
2013/4/30
Martha Stewart Living Omnimedia Inc.'s (MSO) first-quarter loss narrowed as the company trimmed costs, though revenue slumped due to lower print ad sales and as prior-year results included a television show that ended in 2012.
Sign-up for Martha Stewart First-Quarter Loss Narrows on Lower Costs investment picks
2013/5/2
(Adds comments from earnings call and context in paragraphs 4-7) --Valeant CEO won't comment on rumored Actavis talks --Won't preclude acquisition targets if they meet strategy --Some analysts question such a deal By Judy McKinnon and Ben Dummett Valeant Pharmaceuticals International Inc.'s (VRX) first-quarter loss widened, but excluding one-time items, results beat analyst expectations and the company hiked its earnings guidance for the year.
Sign-up for UPDATE:Valeant Posts 1st-Quarter Loss; Adjusted Earnings Beat investment picks
2013/5/2
Valeant Pharmaceuticals International Inc.'s (VRX) first-quarter loss widened, but excluding one-time items, results beat analyst expectations and the company hiked its earnings guidance for the year.
Sign-up for Valeant Posts 1st-Quarter Loss; Adjusted Earnings Beat investment picks
2013/5/1
Prudential Financial Inc.'s (PRU) first-quarter loss narrowed as the insurer posted stronger revenue from premiums, helping mask higher investment losses.
Sign-up for Prudential Financial 1st-Quarter Loss Narrows on Revenue Growth investment picks
2013/5/6
Liberty Global Inc.'s (LBTYA, LBTYB) first-quarter loss narrowed, helped by higher revenue as well as gains on derivatives.
Sign-up for Liberty Global 1st-Quarter Loss Narrows as Revenue Grows investment picks
2013/4/17
Bank of New York Mellon Corp.
Sign-up for Bank of New York Mellon Swings to 1st-Quarter Loss on Tax Costs investment picks
2013/4/29
General Growth Properties Inc.'s (GGP) first-quarter loss narrowed as the mall landlord posted lower warrant liability adjustments and a gain on the extinguishment of debt, while revenue rose.
Sign-up for General Growth 1st-Quarter Loss Narrows on Lower Liability Adjustments, Debt-Extinguishment Gain investment picks
2013/5/2
-- Actavis posts first-quarter loss on acquisition, restructuring charges --Company raises 2013 earnings forecast, citing strong performance --CEO declines comment on reports of M&A talks with Valeant, says company routinely explores deals (Adds details about potential deal talks with Valeant, CEO comments on reports.) By Peter Loftus and Melodie Warner Actavis Inc. (ACT) swung to a first-quarter loss as acquisition, licensing and other charges masked the drug maker's revenue growth, while adjusted earnings topped consensus estimates.
Sign-up for UPDATE: Actavis Swings to 1st-Quarter Loss on Charges; Raises Year View investment picks
2013/5/7
Exelixis Inc.'s (EXEL) first-quarter loss widened as the biotechnology company's revenue declined mostly owing to $ 10.7 million in revenue recognized in the year-earlier period related to a licensing agreement.
Sign-up for Exelixis 1st-Quarter Loss Widened as Revenue Slumps Amid Year-Earlier Impacts investment picks

Start Premium Trial Register For Free

P F Fund Financial Data (13,000+ funds)
P F Stock Financial Data (7,000+ stocks)
P F Stock and Fund Screeners (basic)
P F Investing Articles and Market Commentary
P F Articles Archive (>30 days)
P F Discuss (dozens of stock, fund, bond, and general bulletin boards)
P F Portfolio Manager (basic)
P F Morningstar Investment Classroom
P F Morningstar Investing Classroom Rewards (earn as you learn and redeem for Morningstar merchandise)
P   Morningstar Fund Analyst Reports (full research on 2,000 funds and ETFs)
P   Morningstar Stock Analyst Reports (full research on 2,000 stocks)
P   Morningstar Stock and Fund Stewardship Grades
P   Portfolio Manager (advanced with 10 x-ray analyses, including guidance)
P   Portfolio Monitor (monthly and on-demand personalized portfolio statements)
P   Morningstar Proprietary Stock Information (stock star ratings, buy/sell prices, economic moat ratings, and more)
P   Morningstar Stock and Fund Favorites & Red Flags eNewsletters
P   Premium Stock and Fund Screeners (advanced with nearly infinite ways to find the best securities for you)
P   Discounts on Morningstar newsletters, books, seminars, and more

Sign-up to Morningstar


Basic Access

Articles and Videos
Morningstar video reports, articles, data, and tools. Dig into our lineup of e-newsletters and investing classroom courses outlining sensible strategies for maximizing your investments.
Morningstar Discuss
Follow the buzz on individual stocks or fund families. Plus, read the latest posts from Morningstar members and analysts.
Portfolio Manager
Track your investments and watch lists with our Portfolio Manager. Customize your view with our comprehensive stock, fund, and ETF data.

Access these features and more when you sign up for Free Membership.
Join Morningstar today. It's Free.

Unlimited Access

Analyst Research
Gather in-depth, actionable insight on over 3,700 stock and mutual funds covered by Morningstar analysts. View our mutual fund Analyst Reports favored by professionals, savvy experienced investors, and new investors researching options for retirement savings, college plans, or other investment needs.
Portfolio X-Ray®
Ensure your portfolio is positioned exactly how you want with Morningstar's X-Ray Interpreter and Stock Intersection tools. A Barron's "Best of the Web" award winner for five years running, X-Ray Interpreter goes under the hood of your portfolio to provide a useful allocation, sector, and geographic analysis. And you can discover how much of a stock you really own, individually and through mutual funds, with Stock Intersection.
Investment Picks
Find new 5-star stocks (greatly undervalued companies) to consider daily. Our 5-star stock rating is a proven winner, consistently beating benchmarks like the S&P 500. Plus, browse our Fund Analyst Picks and Stewardship Grades to find shareholder-friendly mutual funds that are poised for outperformance.
Portfolio Monitor
Get a clear view of your investments with personalized reports about your portfolio. Receive monthly statements and generate reports on-demand to help you stay on track to meet your investment goals.

Access these features and more when you sign up for Premium Membership.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.

Quarterly Loss
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Quarterly Investor  |  Next: Quarterly Net